These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1025 related items for PubMed ID: 22559167

  • 1. Novel synergistic antitumor effects of rapamycin with bortezomib on hepatocellular carcinoma cells and orthotopic tumor model.
    Wang C, Gao D, Guo K, Kang X, Jiang K, Sun C, Li Y, Sun L, Shu H, Jin G, Sun H, Wu W, Liu Y.
    BMC Cancer; 2012 May 04; 12():166. PubMed ID: 22559167
    [Abstract] [Full Text] [Related]

  • 2. Synergistic interactions between sorafenib and bortezomib in hepatocellular carcinoma involve PP2A-dependent Akt inactivation.
    Chen KF, Yu HC, Liu TH, Lee SS, Chen PJ, Cheng AL.
    J Hepatol; 2010 Jan 04; 52(1):88-95. PubMed ID: 19913321
    [Abstract] [Full Text] [Related]

  • 3. Down-regulation of phospho-Akt is a major molecular determinant of bortezomib-induced apoptosis in hepatocellular carcinoma cells.
    Chen KF, Yeh PY, Yeh KH, Lu YS, Huang SY, Cheng AL.
    Cancer Res; 2008 Aug 15; 68(16):6698-707. PubMed ID: 18701494
    [Abstract] [Full Text] [Related]

  • 4. mTORC1 Up-Regulates GP73 to Promote Proliferation and Migration of Hepatocellular Carcinoma Cells and Growth of Xenograft Tumors in Mice.
    Chen X, Wang Y, Tao J, Shi Y, Gai X, Huang F, Ma Q, Zhou Z, Chen H, Zhang H, Liu Z, Sun Q, Peng H, Chen R, Jing Y, Yang H, Mao Y, Zhang H.
    Gastroenterology; 2015 Sep 15; 149(3):741-52.e14. PubMed ID: 25980751
    [Abstract] [Full Text] [Related]

  • 5. Curzerene suppresses hepatocellular carcinoma progression through the PI3K/AKT/MTOR pathway.
    Luo Y, Wang Z, Jiang J, Wu S, Zhai Y.
    Rev Invest Clin; 2024 Jul 24; 76(4):173-184. PubMed ID: 39047236
    [Abstract] [Full Text] [Related]

  • 6. SB365 inhibits angiogenesis and induces apoptosis of hepatocellular carcinoma through modulation of PI3K/Akt/mTOR signaling pathway.
    Hong SW, Jung KH, Lee HS, Choi MJ, Son MK, Zheng HM, Hong SS.
    Cancer Sci; 2012 Nov 24; 103(11):1929-37. PubMed ID: 22909393
    [Abstract] [Full Text] [Related]

  • 7. Arenobufagin, a natural bufadienolide from toad venom, induces apoptosis and autophagy in human hepatocellular carcinoma cells through inhibition of PI3K/Akt/mTOR pathway.
    Zhang DM, Liu JS, Deng LJ, Chen MF, Yiu A, Cao HH, Tian HY, Fung KP, Kurihara H, Pan JX, Ye WC.
    Carcinogenesis; 2013 Jun 24; 34(6):1331-42. PubMed ID: 23393227
    [Abstract] [Full Text] [Related]

  • 8. Sustained antitumor activity by co-targeting mTOR and the microtubule with temsirolimus/vinblastine combination in hepatocellular carcinoma.
    Zhou Q, Lui VW, Lau CP, Cheng SH, Ng MH, Cai Y, Chan SL, Yeo W.
    Biochem Pharmacol; 2012 May 01; 83(9):1146-58. PubMed ID: 22285225
    [Abstract] [Full Text] [Related]

  • 9. Isomalto oligosaccharide sulfate inhibits tumor growth and metastasis of hepatocellular carcinoma in nude mice.
    Xiao CL, Tao ZH, Guo L, Li WW, Wan JL, Sun HC, Wang L, Tang ZY, Fan J, Wu WZ.
    BMC Cancer; 2011 Apr 22; 11():150. PubMed ID: 21513518
    [Abstract] [Full Text] [Related]

  • 10. The dual targeting of insulin and insulin-like growth factor 1 receptor enhances the mTOR inhibitor-mediated antitumor efficacy in hepatocellular carcinoma.
    Pivonello C, Negri M, De Martino MC, Napolitano M, de Angelis C, Provvisiero DP, Cuomo G, Auriemma RS, Simeoli C, Izzo F, Colao A, Hofland LJ, Pivonello R.
    Oncotarget; 2016 Mar 01; 7(9):9718-31. PubMed ID: 26756219
    [Abstract] [Full Text] [Related]

  • 11. Combination of cetuximab and rapamycin enhances the therapeutic efficacy in hepatocellular carcinoma.
    Geng J, Li X, Lang X, Qiao C, Hu M, Yang J, Feng J, Lv M.
    Technol Cancer Res Treat; 2014 Aug 01; 13(4):377-85. PubMed ID: 24325131
    [Abstract] [Full Text] [Related]

  • 12. Vertical blockade of the IGFR- PI3K/Akt/mTOR pathway for the treatment of hepatocellular carcinoma: the role of survivin.
    Ou DL, Lee BS, Lin LI, Liou JY, Liao SC, Hsu C, Cheng AL.
    Mol Cancer; 2014 Jan 03; 13():2. PubMed ID: 24387108
    [Abstract] [Full Text] [Related]

  • 13. HS-116, a novel phosphatidylinositol 3-kinase inhibitor induces apoptosis and suppresses angiogenesis of hepatocellular carcinoma through inhibition of the PI3K/AKT/mTOR pathway.
    Jung KH, Choi MJ, Hong S, Lee H, Hong SW, Zheng HM, Lee HS, Hong S, Hong SS.
    Cancer Lett; 2012 Mar 28; 316(2):187-95. PubMed ID: 22182943
    [Abstract] [Full Text] [Related]

  • 14. Preclinical evaluation of combined TKI-258 and RAD001 in hepatocellular carcinoma.
    Chan SL, Wong CH, Lau CP, Zhou Q, Hui CW, Lui VW, Ma BB, Chan AT, Yeo W.
    Cancer Chemother Pharmacol; 2013 Jun 28; 71(6):1417-25. PubMed ID: 23546591
    [Abstract] [Full Text] [Related]

  • 15. Combined targeting of AKT and mTOR synergistically inhibits proliferation of hepatocellular carcinoma cells.
    Grabinski N, Ewald F, Hofmann BT, Staufer K, Schumacher U, Nashan B, Jücker M.
    Mol Cancer; 2012 Nov 20; 11():85. PubMed ID: 23167739
    [Abstract] [Full Text] [Related]

  • 16. Local anesthetic bupivacaine inhibits proliferation and metastasis of hepatocellular carcinoma cells via suppressing PI3K/Akt and MAPK signaling.
    Wang L, Guo W, Guan H, Yan N, Cai X, Zhu L.
    J Biochem Mol Toxicol; 2021 Oct 20; 35(10):e22871. PubMed ID: 34338398
    [Abstract] [Full Text] [Related]

  • 17. Inhibitory effect of oleanolic acid on hepatocellular carcinoma via ERK-p53-mediated cell cycle arrest and mitochondrial-dependent apoptosis.
    Wang X, Bai H, Zhang X, Liu J, Cao P, Liao N, Zhang W, Wang Z, Hai C.
    Carcinogenesis; 2013 Jun 20; 34(6):1323-30. PubMed ID: 23404993
    [Abstract] [Full Text] [Related]

  • 18. Ropivacaine suppresses tumor biological characteristics of human hepatocellular carcinoma via inhibiting IGF-1R/PI3K/AKT/mTOR signaling axis.
    Zhang R, Lian Y, Xie K, Cai Y, Pan Y, Zhu Y.
    Bioengineered; 2021 Dec 20; 12(2):9162-9173. PubMed ID: 34696683
    [Abstract] [Full Text] [Related]

  • 19. An ethyl acetate fraction of Artemisia capillaris (ACE-63) induced apoptosis and anti-angiogenesis via inhibition of PI3K/AKT signaling in hepatocellular carcinoma.
    Jung KH, Rumman M, Yan H, Cheon MJ, Choi JG, Jin X, Park S, Oh MS, Hong SS.
    Phytother Res; 2018 Oct 20; 32(10):2034-2046. PubMed ID: 29972254
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of mTORC2 Induces Cell-Cycle Arrest and Enhances the Cytotoxicity of Doxorubicin by Suppressing MDR1 Expression in HCC Cells.
    Chen BW, Chen W, Liang H, Liu H, Liang C, Zhi X, Hu LQ, Yu XZ, Wei T, Ma T, Xue F, Zheng L, Zhao B, Feng XH, Bai XL, Liang TB.
    Mol Cancer Ther; 2015 Aug 20; 14(8):1805-15. PubMed ID: 26026051
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 52.